Hirsh V. Are the data on quality of life and patient reported outcomes from clinical trials of metastatic non-small-cell lung cancer important? World J Clin Oncol 2013; 4(4): 82-84 [PMID: 24926427 DOI: 10.5306/wjco.v4.i4.82]
Corresponding Author of This Article
Vera Hirsh, MD, FRCP (C), Division of Medical Oncology, McGill University Health Center, 1650 Cedar Ave, Montreal, Quebec H3G 1A4, Canada. vera.hirsh@muhc.mcgill.ca
Research Domain of This Article
Oncology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/